Next 10 |
home / stock / ogn / ogn articles
Organon (NYSE: OGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that ...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...
Organon & Co (NYSE:OGN) reported a 5% Y/Y increase in the first quarter of 2024 revenue, reaching around $1.622 billion, beating the&...
Launched on 04/27/2016, the WisdomTree U.S. High Yield Corporate Bond ETF (BATS: WFHY) is a smart beta exchange traded fund offering broad exposure...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...
The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This...
The Attorney General of New York, Letitia James, has called on the FDA to address safety risks associated with the widely used asthma and alle...
Thursday, Organon & Co (NYSE:OGN) reported an 8% Y/Y increase in the fourth quarter of 2023, reaching around $1.6 billion, beating th...
Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings. Herbalife posted adjusted earnings o...
News, Short Squeeze, Breakout and More Instantly...
2024-06-08 06:50:00 ET Not all dividend stocks are equal. Some are safer than others. Some have much higher dividend yields than others. When a stock offers both advantages, it's usually a keeper. Three Motley Fool contributors have found stocks with mouthwatering dividends that you...
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing authorization applications (MAAs) for HLX14, an investigational Prolia ® and Xgeva ® (denosumab) biosimilar. Denosumab has been a...
2024-05-23 02:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...